Wounds and Injuries Clinical Trial
Official title:
Does an Indian Version of the International Classification of Disease Injury Severity Score Predict Mortality in Four Public Hospitals in Urban India?
In this project, we derive survival risk ratios (SRR) based on International Classification of Disease version 10 (ICD-10) injury codes to validate the ICD Injury Severity Score (ICISS) in data from four public university hospitals in India.
Introduction
In 2013 trauma was estimated to cause 4,8 million deaths, which is more than HIV/AIDS,
tuberculosis, malaria and maternal conditions combined (1). Ninety per cent of these deaths
occur in lower-middle income countries (LMIC) and an estimated two million lives could be
saved annually by improved quality of care (2,3). India is considered a lower-middle income
country with over 1 million annual trauma deaths (1). In 2020 trauma is estimated to be the
third leading cause of death in the country (4). Hence, efforts to strengthen trauma care in
India are urgently needed.
Trauma patients constitute a heterogeneous population, making trauma research and outcome
comparison over time and between contexts difficult but important (5). Accounting for
factors such as selection bias, difference in care and case mix is crucial for correct
conclusions (6,7).To enable this several tools or scores have been developed including the
Injury Severity Score (ISS) and the Trauma and Injury Severity Score (TRISS) (8,9). The use
of these scores as part of quality improvement programmes has been associated with improved
trauma care (10).
In ISS and TRISS the severity assigned to each injury is based on expert consensus. In
contrast, the international classification of disease (ICD) injury severity score (ICISS)
was developed using a more data driven approach (9,11). This score is based on survival risk
ratios assigned to ICD injury codes to estimate an individual patient's probability of
survival. According to a recent systematic review ICISS outperforms ISS derived methods
(12), but so far almost all research on ICISS is from high income countries. Therefore, our
research question is, does an Indian version of ICISS predict mortality in four public
hospitals in urban India?
Study design
We will conduct a retrospective registry based study to derive and temporally validate a new
version of ICISS.
Setting
We will use data from an ongoing prospective cohort study called Towards Improved Trauma
Care Outcomes (TITCO) in India that started in four public university hospitals across urban
India. The four centres are Lokmanya Tilak Municipal General Hospital in Mumbai, King Edward
Memorial Hospital in Mumbai, Jai Prakash Narayan Apex Trauma Center in Delhi, and the
Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial
Hospital in Kolkata. The data used in this study was collected between October 2013 and
January 2015.
Trained project officers conducted all data collection. The project officers had a health
master's degree or higher education. They worked eight hours a day and rotated between day,
evening and night shifts. There was one project officer for each hospital. The project
officers where continuously supervised and trained by project management. Patients were
followed up until discharge, death or 30 days, whichever came first.
Source and method of participant selection
Project officers included all consecutive patients that fitted the eligibility criteria.
Data for patients admitted during the project officers' shifts were collected using a
combination of direct observation and extraction from patient records. Data for patients
admitted outside of their shifts was collected retrospectively from patient records within
days of patient arrival. All patients discharged before 30 days where considered alive at 30
days.
Data sources/measurements
Data on covariates were extracted from patient records or from the patients or their
accompanying relatives. Injuries were also extracted from patient records, including imaging
reports and operation notes and were then coded using ICD-10. We will calculate the SRR for
to each unique ICD-10 code using SRR=A/(A+B), where A denotes the number of surviving
patients with a specific ICD-code and B is the number of non-surviving patients with the
same specific ICD-code. The calculated SRR gets a value between zero and one. One represents
100% survival and zero represents 0% survival. We will calculate the final ICISS score for
each patient as the product of all individual SRRs. Hence, ICISS also ranges from 0 to 1 and
should be interpreted as the patient's probability of survival. This method is commonly
referred to as the conventional ICISS.
Bias
The personal collecting the data were observers and did not take part in the actual care.
During the conversion from injuries in free text to ICD-10 codes the coders will be blinded
to patient demographics and outcomes. ICD-10 coding will be done after completing World
Health Organization (WHO) ICD-10 online training module and after achieving over 80%
agreement in several samples of 50 injuries compared to an external coder.
Study size
We will use all available data from TITCO and create a temporal split sample, using the
earlier data for derivation and the most recent data for validation. These two samples are
henceforth referred to as the derivation sample and validation sample respectively. We will
first estimate the required sample size of the validation sample to include the most recent
200 consecutive events, i.e. patients who died within 24 hours, and all non-events enrolled
during the same time period.
We use mortality within 24 hours for our sample size calculation as we want the study to be
powered for secondary outcomes also. This effective sample size will allow us to detect a
significant difference in discrimination and calibration of ICISS between derivation and
calibration samples at 80% power and a 5% significance level. We will include all remaining
patients in the derivation sample.
Quantitative variables
We will analyse all quantitative variables as continuous.
Statistical methods and analyses
The derivation and validation of ICISS will be conducted as two separate steps, described
below. We will use R for all statistical analyses. We will assess predictive performance in
terms of discrimination and calibration. Discrimination will be assessed by calculating the
area under the receiver operating characteristics curve (AUROCC) and calibration will be
assessed by comparing observed and predicted outcomes visually in a calibration plot and
statistically by calculating the calibration slope. Confidence intervals for predictive
performance measures will be estimated using a bootstrap approach.
We interpret overlapping confidence intervals as evidence of lack of a significant
difference. Parametric and non-parametric exact tests will be used as appropriate, with 95%
confidence intervals and a 5% significance level. Our main analysis will be a complete case
analysis, in which we exclude observations with missing values in any of the following
variables: age, sex, mechanism of injury, transfer status, and outcome. Observations with no
injuries reported will be assigned an ICISS of 1 and for each observation the final ICISS
will be calculated based only on SRR for ICD-codes that occurred in at least 10 observations
in the derivation sample.
Derivation
We will derive SRR in the derivation sample for each of the outcomes and used them to
calculate ICISS for each patient. In other words, we will calculate one set of SRR for
mortality within 30 days, henceforth referred to as SRR-30D, and one set of SRR for
mortality within 24 hours, henceforth referred to as SRR-24H. We will then calculate two
ICISS for each patient. We will use similar denotation to refer to these ICISS, i.e.
ICISS-30D and ICISS-24H. Finally, we will assess the performance of ICISS-30D in predicting
mortality within 30 days and within 24 hours, and repeated this analysis for ICISS-24H.
Validation
We will use the SRR-30D and SRR-24H that we derive in the derivation sample to calculate
ICISS-30D and ICISS-24H in the validation sample. We will then assess the performance of
ICISS-30D in predicting mortality within 30 days and within 24 hours, and the performance of
ICISS-24H in predicting mortality within 30 days and within 24 hours. Finally, the
performance of each model in the validation sample will be compared with the same model's
performance in the derivation sample.
Sensitivity analyses
We will conduct four sensitivity analyses. In the first sensitivity analysis we will include
observations with missing values in covariates but with complete outcome data. In the second
sensitivity analysis we exclude observations without any reported injury. In the third
sensitivity analysis we will calculate ICISS based on all available SRR, regardless of how
frequently the corresponding ICD-10 codes occurr in the dataset. Finally, we will calculate
ICISS for each patient based only on unique ICD-10 codes, in other words, each ICD-10 code
will only be allowed to contribute one SRR to ICISS even if it occurrs more than once in the
same patient.
1. Global, regional, and national age-sex specific all-cause and cause-specific mortality
for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of
Disease Study 2013. Lancet [Internet]. 2014 Dec 17 [cited 2014 Dec
19];385(9963):117-71. Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4340604&tool=pmcentrez&rendertype=abstract
2. Chandran A, Hyder AA, Peek-Asa C. The global burden of unintentional injuries and an
agenda for progress. Epidemiol Rev [Internet]. 2010 Jan [cited 2015 Dec 6];32:110-20.
Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2912603&tool=pmcentrez&rendertype=abstract
3. Mock C, Joshipura M, Arreola-Risa C, Quansah R. An estimate of the Number of Lives that
Could be Saved through Improvements in Trauma Care Globally. World J Surg.
2012;36(5):959-63.
4. Joshipura MK. Trauma care in India: current scenario. World J Surg [Internet]. 2008 Aug
[cited 2016 Jan 19];32(8):1613-7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/18553048
5. Rutledge R. The goals, development, and use of trauma registries and trauma data
sources in decision making in injury. Surg Clin North Am [Internet]. 1995 Apr [cited
2016 Feb 22];75(2):305-26. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7900000
6. Newgard CD, Fildes JJ, Wu L, Hemmila MR, Burd RS, Neal M, et al. Methodology and
analytic rationale for the American College of Surgeons Trauma Quality Improvement
Program. J Am Coll Surg [Internet]. 2013 Jan [cited 2016 Feb 22];216(1):147-57.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23062519
7. Krumholz HM. Mathematical models and the assessment of performance in cardiology.
Circulation [Internet]. 1999 Apr 27 [cited 2016 Feb 22];99(16):2067-9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/10217642
8. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a method for
describing patients with multiple injuries and evaluating emergency care. J Trauma
[Internet]. 1974 Mar [cited 2015 Apr 16];14(3):187-96. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/4814394
9. Rutledge R, Osler T, Emery S, Kromhout-Schiro S. The end of the Injury Severity Score
(ISS) and the Trauma and Injury Severity Score (TRISS): ICISS, an International
Classification of Diseases, ninth revision-based prediction tool, outperforms both ISS
and TRISS as predictors of trauma patient survival,. J Trauma [Internet]. 1998 Jan
[cited 2016 Feb 15];44(1):41-9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/9464748
10. Glance LG, Osler T. Beyond the major trauma outcome study: benchmarking performance
using a national contemporary, population-based trauma registry. J Trauma [Internet].
2001 Oct [cited 2016 Feb 22];51(4):725-7. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/11586166
11. Meredith JW, Evans G, Kilgo PD, MacKenzie E, Osler T, McGwin G, et al. A comparison of
the abilities of nine scoring algorithms in predicting mortality. J Trauma [Internet].
2002 Oct [cited 2016 Feb 22];53(4):621-8; discussion 628-9. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/12394857
12. Gagné M, Moore L, Beaudoin C, Batomen Kuimi BL, Sirois M-J. Performance of ICD-based
injury severity measures used to predict in-hospital mortality: a systematic review and
meta-analysis. J Trauma Acute Care Surg [Internet]. 2015 Dec 26 [cited 2016 Feb 4];
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26713976
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04554212 -
Blood Flow Restriction Training After Patellar INStability
|
N/A | |
| Suspended |
NCT02932176 -
Machine Learning for Handheld Vascular Studies
|
||
| Recruiting |
NCT04803253 -
Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation
|
N/A | |
| Completed |
NCT00116337 -
Spinal Cord Stimulation to Restore Cough
|
N/A | |
| Completed |
NCT03463720 -
Outcome for Patients With War-Associated Extremity Wound Infection
|
N/A | |
| Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
| Not yet recruiting |
NCT05492903 -
COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)
|
N/A | |
| Terminated |
NCT02909231 -
One-year Patient Reported Outcomes Following Hospitalization for Trauma
|
N/A | |
| Completed |
NCT02432456 -
Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients
|
Phase 4 | |
| Completed |
NCT02266771 -
Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice
|
N/A | |
| Completed |
NCT02744144 -
Wound Bacterial Microbiota and Their Antibiotic Resistance
|
N/A | |
| Completed |
NCT02394821 -
Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide
|
Phase 3 | |
| Not yet recruiting |
NCT01665963 -
Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds
|
N/A | |
| Completed |
NCT00151112 -
Comparison of Two Different Procedures for Plexus Anesthesia
|
N/A | |
| Not yet recruiting |
NCT03872544 -
Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
| Recruiting |
NCT04596124 -
Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze
|
N/A | |
| Recruiting |
NCT05800834 -
Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds
|
Phase 2 | |
| Enrolling by invitation |
NCT03880188 -
Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
|
||
| Terminated |
NCT04775316 -
Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
|
||
| Enrolling by invitation |
NCT03312504 -
Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training
|
N/A |